Research Interests

• Zhao Wei-Li, M.D., PhD, Professor of Hematology, First Deputy Director of Shanghai Institute of Hematology and Vice President of Shanghai Ruijin Hospital. She mainly focuses on the clinical and basic research of hematological malignancies, especially the molecular mechanism and targeted therapy of malignant lymphoma. She innovatively proposed the molecular pathways of apoptosis, angiogenesis and cell differentiation involved in lymphoma progression and the availability of targeted agents for treatment. She has been awarded National Award and is now leading projects granted by National High Technology Research and Development Program of China. She has published over 100 articles on leading hematology journals with total impact factors over 1200.